These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19317236)

  • 1. Clinical profile and management of brucellosis in Tehran - Iran.
    Hadadi A; Rasoulinejad M; HajiAbdolbaghi M; Mohraz M; Khashayar P
    Acta Clin Belg; 2009; 64(1):11-5. PubMed ID: 19317236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic, clinical and laboratory findings of patients with brucellosis in Hamadan, west of Iran.
    Eini P; Keramat F; Hasanzadehhoseinabadi M
    J Res Health Sci; 2012 Dec; 12(2):105-8. PubMed ID: 23241521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature.
    Buzgan T; Karahocagil MK; Irmak H; Baran AI; Karsen H; Evirgen O; Akdeniz H
    Int J Infect Dis; 2010 Jun; 14(6):e469-78. PubMed ID: 19910232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran.
    Hashemi SH; Keramat F; Ranjbar M; Mamani M; Farzam A; Jamal-Omidi S
    Int J Infect Dis; 2007 Nov; 11(6):496-500. PubMed ID: 17344084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations, laboratory findings, and therapeutic regimen in hospitalized children with brucellosis in an Iranian Referral Children Medical Centre.
    Fanni F; Shahbaznejad L; Pourakbari B; Mahmoudi S; Mamishi S
    J Health Popul Nutr; 2013 Jun; 31(2):218-22. PubMed ID: 23930340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.
    Sofian M; Velayati AA; Aghakhani A; McFarland W; Farazi AA; Banifazl M; Eslamifar A; Ramezani A
    Scand J Infect Dis; 2014 Aug; 46(8):573-7. PubMed ID: 24934986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and duration of disease as factors affecting clinical findings and sacroiliitis in brucellosis.
    Hizel K; Guzel O; Dizbay M; Karakus R; Senol E; Arman D; Aktas F; Ulutan F
    Infection; 2007 Dec; 35(6):434-7. PubMed ID: 17906836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical manifestations, complications and treatment of brucellosis: 45-patient study].
    Zribi M; Ammari L; Masmoudi A; Tiouiri H; Fendri C
    Pathol Biol (Paris); 2009 Jul; 57(5):349-52. PubMed ID: 18387752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.
    Hasanjani Roushan MR; Mohraz M; Hajiahmadi M; Ramzani A; Valayati AA
    Clin Infect Dis; 2006 Apr; 42(8):1075-80. PubMed ID: 16575723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella endocarditis: a report from Iran.
    Esmailpour N; Borna S; Nejad MR; Badie SM; Badie BM; Hadadi A
    Trop Doct; 2010 Jan; 40(1):47-9. PubMed ID: 19850601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucellosis in central Anatolia: evaluation of complications and relapse.
    Naz H; Aykin N; Cevik F; Bal C
    Trop Doct; 2009 Apr; 39(2):107-9. PubMed ID: 19299298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
    Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
    Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran.
    Hasanjani Roushan MR; Mohrez M; Smailnejad Gangi SM; Soleimani Amiri MJ; Hajiahmadi M
    Epidemiol Infect; 2004 Dec; 132(6):1109-14. PubMed ID: 15635968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, complications and treatment outcome of childhood brucellosis in central Greece.
    Tsolia M; Drakonaki S; Messaritaki A; Farmakakis T; Kostaki M; Tsapra H; Karpathios T
    J Infect; 2002 May; 44(4):257-62. PubMed ID: 12099734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory features of brucellosis in two university hospitals in Southeast Turkey.
    Kokoglu OF; Hosoglu S; Geyik MF; Ayaz C; Akalin S; Buyukbese MA; Cetinkaya A
    Trop Doct; 2006 Jan; 36(1):49-51. PubMed ID: 16483439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human brucellosis in Macedonia - 10 years of clinical experience in endemic region.
    Bosilkovski M; Krteva L; Dimzova M; Vidinic I; Sopova Z; Spasovska K
    Croat Med J; 2010 Aug; 51(4):327-36. PubMed ID: 20718086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of treatment in 50 cases with spinal brucellosis in Babol, Northern Iran.
    Smailnejad Gangi SM; Hasanjani Roushan MR; Janmohammadi N; Mehraeen R; Soleimani Amiri MJ; Khalilian E
    J Infect Dev Ctries; 2012 Sep; 6(9):654-9. PubMed ID: 23000864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
    Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
    Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory features, complications and treatment outcome of brucellosis in childhood and review of the literature.
    Uluğ M; Yaman Y; Yapici F; Can-Uluğ N
    Turk J Pediatr; 2011; 53(4):413-24. PubMed ID: 21980844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Relapse of Human Brucellosis.
    Hasanjani Roushan MR; Moulana Z; Mohseni Afshar Z; Ebrahimpour S
    Glob J Health Sci; 2015 Nov; 8(7):77-82. PubMed ID: 26925907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.